These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 3301170)

  • 21. Characterization of drug-protein binding process by employing equilibrium sampling through hollow-fiber supported liquid membrane and Bjerrum and Scatchard plots.
    Barri T; Trtić-Petrović T; Karlsson M; Jönsson JA
    J Pharm Biomed Anal; 2008 Sep; 48(1):49-56. PubMed ID: 18565712
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A pressure ultrafiltration method for serum free drug determination. Comparison with equilibrium dialysis using normal and uraemic sera.
    Tiula E
    Methods Find Exp Clin Pharmacol; 1984 Jan; 6(1):51-5. PubMed ID: 6717171
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anomalous relationship between free drug fraction and its total concentration in drug-protein systems II. Binding of different ligands to plasma proteins.
    Dawidowicz AL; Kobielski M; Pieniadz J
    Eur J Pharm Sci; 2008 Sep; 35(1-2):136-41. PubMed ID: 18644440
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Drug-protein interactions and their clinical significance.
    Gabourel JD
    Adv Biol Skin; 1972; 12():51-60. PubMed ID: 4579205
    [No Abstract]   [Full Text] [Related]  

  • 25. Blood binding and tissue transfer of drugs: the influence of alpha 1 acid glycoprotein binding.
    Belaiba R; Riant P; Urien S; Brée F; Albengres E; Barré J; Tillement JP
    Prog Clin Biol Res; 1989; 300():287-305. PubMed ID: 2674966
    [No Abstract]   [Full Text] [Related]  

  • 26. Serum protein binding of drugs during and after pregnancy in rats.
    Stock B; Dean M; Levy G
    J Pharmacol Exp Ther; 1980 Feb; 212(2):264-8. PubMed ID: 7351638
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Determination of unbound drug concentration and protein-drug binding fraction in plasma.
    Liu Z; Li F; Huang Y
    Biomed Chromatogr; 1999 Jun; 13(4):262-6. PubMed ID: 10416057
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Free plasma drug concentration].
    Durán JA; Abadín JA
    Med Clin (Barc); 1988 Nov; 91(16):618-20. PubMed ID: 3230963
    [No Abstract]   [Full Text] [Related]  

  • 29. Elementary pharmacokinetics in clinical practice. 6: Drug concentration monitoring.
    Paxton JW
    N Z Med J; 1982 Mar; 95(703):150-3. PubMed ID: 6952127
    [No Abstract]   [Full Text] [Related]  

  • 30. The effects of selected drugs on the in vitro protein binding of repaglinide in human plasma.
    Plum A; Müller LK; Jansen JA
    Methods Find Exp Clin Pharmacol; 2000 Apr; 22(3):139-43. PubMed ID: 10893694
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasma drug concentrations in therapeutics.
    Hooper WD; Tyrer JH; Eadie MJ
    Med J Aust; 1976 Mar; 1(10):313-9. PubMed ID: 1272103
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Equilibrium gel filtration to measure plasma protein binding of very highly bound drugs.
    Weiss HM; Gatlik E
    J Pharm Sci; 2014 Feb; 103(2):752-9. PubMed ID: 24375113
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Compilation of 222 drugs' plasma protein binding data and guidance for study designs.
    Zhang F; Xue J; Shao J; Jia L
    Drug Discov Today; 2012 May; 17(9-10):475-85. PubMed ID: 22210121
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Proceedings: Factors responsible for different binding of drugs to plasma proteins of newborn and adults.
    Stickel H; Kurz H; Michels H
    Naunyn Schmiedebergs Arch Pharmacol; 1975; 287 Suppl():R67. PubMed ID: 1143476
    [No Abstract]   [Full Text] [Related]  

  • 35. Rationale for monitoring free drug levels.
    Levy RH; Moreland TA
    Clin Pharmacokinet; 1984 Jan; 9 Suppl 1():1-9. PubMed ID: 6705421
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differences in the binding of drugs to plasma proteins from newborn and adult man. I.
    Kurz H; Mauser-Ganshorn A; Stickel HH
    Eur J Clin Pharmacol; 1977 Jul; 11(6):463-7. PubMed ID: 891592
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Disease-induced changes in the plasma binding of basic drugs.
    Piafsky KM
    Clin Pharmacokinet; 1980; 5(3):246-62. PubMed ID: 6156048
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dosage monitoring through measurement of serum level--a task of clinical pharmacology.
    Walther H; Meyer FP; Quednow B; Leuschner U; Köhler E; Horenburg I
    Int J Clin Pharmacol Biopharm; 1978 Aug; 16(8):387-90. PubMed ID: 689799
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessment of the contribution of alpha 1-acid glycoprotein to the serum binding of basic drugs using serum treated with sulphosalicylic acid and DEAE-cellulose.
    Suzuki Y; Sugiyama Y; Sawada Y; Iga T; Hanano M
    J Pharm Pharmacol; 1985 Oct; 37(10):712-7. PubMed ID: 2867139
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of the erythrocyte partitioning method with two classical methods for estimating free drug fraction in plasma.
    Trung AH; Sirois G; Dubé LM; McGilveray IJ
    Biopharm Drug Dispos; 1984; 5(3):281-90. PubMed ID: 6487754
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.